首页 > 最新文献

Journal of Systems Science & Complexity最新文献

英文 中文
Statistical Identification of Important Nodes in Biological Systems. 生物系统中重要节点的统计识别。
IF 2.1 3区 数学 Q1 MATHEMATICS, INTERDISCIPLINARY APPLICATIONS Pub Date : 2021-01-01 Epub Date: 2021-08-10 DOI: 10.1007/s11424-020-0013-0
Pei Wang

Biological systems can be modeled and described by biological networks. Biological networks are typical complex networks with widely real-world applications. Many problems arising in biological systems can be boiled down to the identification of important nodes. For example, biomedical researchers frequently need to identify important genes that potentially leaded to disease phenotypes in animal and explore crucial genes that were responsible for stress responsiveness in plants. To facilitate the identification of important nodes in biological systems, one needs to know network structures or behavioral data of nodes (such as gene expression data). If network topology was known, various centrality measures can be developed to solve the problem; while if only behavioral data of nodes were given, some sophisticated statistical methods can be employed. This paper reviewed some of the recent works on statistical identification of important nodes in biological systems from three aspects, that is, 1) in general complex networks based on complex networks theory and epidemic dynamic models; 2) in biological networks based on network motifs; and 3) in plants based on RNA-seq data. The identification of important nodes in a complex system can be seen as a mapping from the system to the ranking score vector of nodes, such mapping is not necessarily with explicit form. The three aspects reflected three typical approaches on ranking nodes in biological systems and can be integrated into one general framework. This paper also proposed some challenges and future works on the related topics. The associated investigations have potential real-world applications in the control of biological systems, network medicine and new variety cultivation of crops.

生物系统可以用生物网络来建模和描述。生物网络是典型的复杂网络,在现实世界中有着广泛的应用。生物系统中出现的许多问题都可以归结为重要节点的识别。例如,生物医学研究人员经常需要识别可能导致动物疾病表型的重要基因,探索导致植物应激反应的关键基因。为便于识别生物系统中的重要节点,人们需要了解节点的网络结构或行为数据(如基因表达数据)。如果已知网络拓扑结构,则可以开发各种中心度量来解决问题;如果只给出节点的行为数据,则可以采用一些复杂的统计方法。本文从三个方面综述了近期关于生物系统中重要节点统计识别的一些工作,即:1)基于复杂网络理论和流行病动态模型的一般复杂网络;2)基于网络图案的生物网络;3)基于 RNA-seq 数据的植物网络。复杂系统中重要节点的识别可以看作是从系统到节点排名得分向量的映射,这种映射不一定具有明确的形式。这三个方面反映了生物系统中节点排序的三种典型方法,可以整合为一个总体框架。本文还就相关主题提出了一些挑战和未来工作。相关研究在生物系统控制、网络医学和农作物新品种培育方面具有潜在的现实应用前景。
{"title":"Statistical Identification of Important Nodes in Biological Systems.","authors":"Pei Wang","doi":"10.1007/s11424-020-0013-0","DOIUrl":"10.1007/s11424-020-0013-0","url":null,"abstract":"<p><p>Biological systems can be modeled and described by biological networks. Biological networks are typical complex networks with widely real-world applications. Many problems arising in biological systems can be boiled down to the identification of important nodes. For example, biomedical researchers frequently need to identify important genes that potentially leaded to disease phenotypes in animal and explore crucial genes that were responsible for stress responsiveness in plants. To facilitate the identification of important nodes in biological systems, one needs to know network structures or behavioral data of nodes (such as gene expression data). If network topology was known, various centrality measures can be developed to solve the problem; while if only behavioral data of nodes were given, some sophisticated statistical methods can be employed. This paper reviewed some of the recent works on statistical identification of important nodes in biological systems from three aspects, that is, 1) in general complex networks based on complex networks theory and epidemic dynamic models; 2) in biological networks based on network motifs; and 3) in plants based on RNA-seq data. The identification of important nodes in a complex system can be seen as a mapping from the system to the ranking score vector of nodes, such mapping is not necessarily with explicit form. The three aspects reflected three typical approaches on ranking nodes in biological systems and can be integrated into one general framework. This paper also proposed some challenges and future works on the related topics. The associated investigations have potential real-world applications in the control of biological systems, network medicine and new variety cultivation of crops.</p>","PeriodicalId":50026,"journal":{"name":"Journal of Systems Science & Complexity","volume":"34 4","pages":"1454-1470"},"PeriodicalIF":2.1,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353063/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39314100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"数学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Agent's Optimal Compensation Under Inflation Risk by Using Dynamic Contract Model. 通货膨胀风险下代理人最优补偿的动态契约模型。
3区 数学 Q1 MATHEMATICS, INTERDISCIPLINARY APPLICATIONS Pub Date : 2021-01-01 Epub Date: 2022-01-11 DOI: 10.1007/s11424-021-0008-5
Chen Fei, Weiyin Fei, Fanhong Zhang, Xiaoguang Yang

This paper studies the problem of principal-agent with moral hazard in continuous time. The firm's cash flow is described by geometric Brownian motion (hereafter GBM). The agent affects the drift of the firm's cash flow by her hidden effort. Meanwhile, the firm rewards the agent with corresponding compensation and equity which depend on the output. The model extends dynamic optimal contract theory to an inflation environment. Firstly, the authors obtain the dynamic equation of the firm's real cash flow under inflation by using the Itô formula. Then, the authors use the martingale representation theorem to obtain agent's continuation value process. Moreover, the authors derive the Hamilton-Jacobi-Bellman (HJB) equation of investor's value process, from which the authors derive the investors' scaled value function by solving the second-order ordinary differential equation. Comparing with He[1], the authors find that inflation risk affects the agent's optimal compensation depending on the firm's position in the market.

研究了连续时间条件下具有道德风险的委托代理问题。公司的现金流用几何布朗运动(以下简称GBM)来描述。代理人通过她的隐性努力影响了公司现金流的流动。同时,企业根据产出给予代理人相应的报酬和权益。该模型将动态最优契约理论推广到通货膨胀环境。首先,利用Itô公式得到通货膨胀条件下企业实际现金流量的动态方程。然后,利用鞅表示定理得到了智能体的连续值过程。推导出投资者价值过程的Hamilton-Jacobi-Bellman (HJB)方程,并通过求解二阶常微分方程推导出投资者的标度价值函数。与He[1]相比,作者发现通货膨胀风险会影响代理的最优报酬,这取决于企业在市场中的地位。
{"title":"Agent's Optimal Compensation Under Inflation Risk by Using Dynamic Contract Model.","authors":"Chen Fei,&nbsp;Weiyin Fei,&nbsp;Fanhong Zhang,&nbsp;Xiaoguang Yang","doi":"10.1007/s11424-021-0008-5","DOIUrl":"https://doi.org/10.1007/s11424-021-0008-5","url":null,"abstract":"<p><p>This paper studies the problem of principal-agent with moral hazard in continuous time. The firm's cash flow is described by geometric Brownian motion (hereafter GBM). The agent affects the drift of the firm's cash flow by her hidden effort. Meanwhile, the firm rewards the agent with corresponding compensation and equity which depend on the output. The model extends dynamic optimal contract theory to an inflation environment. Firstly, the authors obtain the dynamic equation of the firm's real cash flow under inflation by using the Itô formula. Then, the authors use the martingale representation theorem to obtain agent's continuation value process. Moreover, the authors derive the Hamilton-Jacobi-Bellman (HJB) equation of investor's value process, from which the authors derive the investors' scaled value function by solving the second-order ordinary differential equation. Comparing with He<sup>[1]</sup>, the authors find that inflation risk affects the agent's optimal compensation depending on the firm's position in the market.</p>","PeriodicalId":50026,"journal":{"name":"Journal of Systems Science & Complexity","volume":"34 6","pages":"2291-2309"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748525/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39914987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"数学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Complex Dynamics of Hepatitis B Infected Individuals with Optimal Control. 最优控制下乙型肝炎感染个体的复杂动力学。
3区 数学 Q1 MATHEMATICS, INTERDISCIPLINARY APPLICATIONS Pub Date : 2021-01-01 Epub Date: 2021-02-04 DOI: 10.1007/s11424-021-0053-0
Anwarud Din, Yongjin Li, Murad Ali Shah

This paper proposes various stages of the hepatitis B virus (HBV) besides its transmissibility and nonlinear incidence rate to develop an epidemic model. The authors plan the model, and then prove some basic results for the well-posedness in term of boundedness and positivity. Moreover, the authors find the threshold parameter R 0, called the basic/effective reproductive number and carry out local sensitive analysis. Furthermore, the authors examine stability and hence condition for stability in terms of R 0. By using sensitivity analysis, the authors formulate a control problem in order to eradicate HBV from the population and proved that the control problem actually exists. The complete characterization of the optimum system was achieved by using the 4th-order Runge-Kutta procedure.

本文提出了乙型肝炎病毒(HBV)在传播率和非线性发病率之外的各个阶段,建立了一个流行模型。首先对模型进行了规划,然后从有界性和正性两个方面证明了模型的适定性。并求出阈值参数r0,称为基本/有效繁殖数,并进行局部敏感性分析。此外,作者检验了稳定性,从而在r0方面的稳定性条件。通过敏感性分析,提出了从人群中根除HBV的控制问题,并证明了控制问题的存在。利用四阶龙格-库塔过程对最优系统进行了完整表征。
{"title":"The Complex Dynamics of Hepatitis B Infected Individuals with Optimal Control.","authors":"Anwarud Din,&nbsp;Yongjin Li,&nbsp;Murad Ali Shah","doi":"10.1007/s11424-021-0053-0","DOIUrl":"https://doi.org/10.1007/s11424-021-0053-0","url":null,"abstract":"<p><p>This paper proposes various stages of the hepatitis B virus (HBV) besides its transmissibility and nonlinear incidence rate to develop an epidemic model. The authors plan the model, and then prove some basic results for the well-posedness in term of boundedness and positivity. Moreover, the authors find the threshold parameter <i>R</i> <sub>0</sub>, called the basic/effective reproductive number and carry out local sensitive analysis. Furthermore, the authors examine stability and hence condition for stability in terms of <i>R</i> <sub>0</sub>. By using sensitivity analysis, the authors formulate a control problem in order to eradicate HBV from the population and proved that the control problem actually exists. The complete characterization of the optimum system was achieved by using the 4<sup>th</sup>-order Runge-Kutta procedure.</p>","PeriodicalId":50026,"journal":{"name":"Journal of Systems Science & Complexity","volume":"34 4","pages":"1301-1323"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11424-021-0053-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25351230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"数学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 38
Quality of Adherence to the ARRIVE Guidelines in the Material and Methods Section in Studies Where Swine Were Used as Surgical Biomodels: A Systematic Review (2013-2018). 在使用猪作为外科生物模型的研究中,材料和方法部分遵守 ARRIVE 指南的质量:系统回顾(2013-2018年)》。
IF 2.7 3区 数学 Q1 MATHEMATICS, INTERDISCIPLINARY APPLICATIONS Pub Date : 2019-11-11 DOI: 10.3390/ani9110947
Jilma Alemán-Laporte, Gilbert Alvarado, Mariana Sa Garcia-Gomes, Ana Tada Fonseca Brasil Antiorio, Marco Zúñiga-Montero, Claudia Madalena Cabrera Mori

Over the last two decades, pigs have become animal biomodels widely used for the investigation and practice of surgical techniques because of their great physiological and anatomical similarities to humans. Even though many of these studies must be carried out later in humans, the description of basic information is limited, making exact repetitions of the reported experimental methods impossible. In this review, 108 studies from 2013 to 2018 were considered to determine the quality of adherence to the ARRIVE guidelines in the reports of the methodologies. The majority of the studies lacked the details recommended in the ARRIVE guidelines regarding data directly related to the welfare of animals undergoing surgery and those about anesthetic protocols and analgesics. Information related to sample size calculation and housing and husbandry conditions was also very limited. We believe that the ARRIVE guidelines are an excellent tool for good-quality reporting. We encourage scientists to consistently use them as a tool to improve the quality of their scientific reports and, consequently, ensure animal welfare.

在过去的二十年里,猪因其生理和解剖结构与人类极为相似,已成为广泛用于外科技术研究和实践的动物生物模型。尽管许多研究必须在人类身上进行,但基本信息的描述有限,因此不可能完全重复所报道的实验方法。在本次综述中,我们考虑了2013年至2018年的108项研究,以确定方法报告中遵守ARRIVE指南的质量。大多数研究缺乏ARRIVE指南中建议的与手术动物福利直接相关的数据细节,以及有关麻醉方案和镇痛剂的数据细节。与样本量计算以及饲养条件相关的信息也非常有限。我们相信,ARRIVE指南是高质量报告的绝佳工具。我们鼓励科学家坚持将其作为提高科学报告质量的工具,从而确保动物福利。
{"title":"Quality of Adherence to the ARRIVE Guidelines in the Material and Methods Section in Studies Where Swine Were Used as Surgical Biomodels: A Systematic Review (2013-2018).","authors":"Jilma Alemán-Laporte, Gilbert Alvarado, Mariana Sa Garcia-Gomes, Ana Tada Fonseca Brasil Antiorio, Marco Zúñiga-Montero, Claudia Madalena Cabrera Mori","doi":"10.3390/ani9110947","DOIUrl":"10.3390/ani9110947","url":null,"abstract":"<p><p>Over the last two decades, pigs have become animal biomodels widely used for the investigation and practice of surgical techniques because of their great physiological and anatomical similarities to humans. Even though many of these studies must be carried out later in humans, the description of basic information is limited, making exact repetitions of the reported experimental methods impossible. In this review, 108 studies from 2013 to 2018 were considered to determine the quality of adherence to the ARRIVE guidelines in the reports of the methodologies. The majority of the studies lacked the details recommended in the ARRIVE guidelines regarding data directly related to the welfare of animals undergoing surgery and those about anesthetic protocols and analgesics. Information related to sample size calculation and housing and husbandry conditions was also very limited. We believe that the ARRIVE guidelines are an excellent tool for good-quality reporting. We encourage scientists to consistently use them as a tool to improve the quality of their scientific reports and, consequently, ensure animal welfare.</p>","PeriodicalId":50026,"journal":{"name":"Journal of Systems Science & Complexity","volume":"35 1","pages":""},"PeriodicalIF":2.7,"publicationDate":"2019-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912630/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74608965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"数学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial. 轻度或中度阿尔茨海默病患者接受 tau-aggregation 抑制剂治疗的疗效和安全性:一项随机、对照、双盲、平行臂 3 期试验。
3区 数学 Q1 MATHEMATICS, INTERDISCIPLINARY APPLICATIONS Pub Date : 2016-12-10 Epub Date: 2016-11-16 DOI: 10.1016/S0140-6736(16)31275-2
Serge Gauthier, Howard H Feldman, Lon S Schneider, Gordon K Wilcock, Giovanni B Frisoni, Jiri H Hardlund, Hans J Moebius, Peter Bentham, Karin A Kook, Damon J Wischik, Bjoern O Schelter, Charles S Davis, Roger T Staff, Luc Bracoud, Kohkan Shamsi, John M D Storey, Charles R Harrington, Claude M Wischik
<p><strong>Background: </strong>Leuco-methylthioninium bis(hydromethanesulfonate; LMTM), a stable reduced form of the methylthioninium moiety, acts as a selective inhibitor of tau protein aggregation both in vitro and in transgenic mouse models. Methylthioninium chloride has previously shown potential efficacy as monotherapy in patients with Alzheimer's disease. We aimed to determine whether LMTM was safe and effective in modifying disease progression in patients with mild to moderate Alzheimer's disease.</p><p><strong>Methods: </strong>We did a 15-month, randomised, controlled double-blind, parallel-group trial at 115 academic centres and private research clinics in 16 countries in Europe, North America, Asia, and Russia with patients younger than 90 years with mild to moderate Alzheimer's disease. Patients concomitantly using other medicines for Alzheimer's disease were permitted to be included because we considered it infeasible not to allow their inclusion; however, patients using medicines carrying warnings of methaemoglobinaemia were excluded because the oxidised form of methylthioninium in high doses has been shown to induce this condition. We randomly assigned participants (3:3:4) to 75 mg LMTM twice a day, 125 mg LMTM twice a day, or control (4 mg LMTM twice a day to maintain blinding with respect to urine or faecal discolouration) administered as oral tablets. We did the randomisation with an interactive web response system using 600 blocks of length ten, and stratified patients by severity of disease, global region, whether they were concomitantly using Alzheimer's disease-labelled medications, and site PET capability. Participants, their study partners (generally carers), and all assessors were masked to treatment assignment throughout the study. The coprimary outcomes were progression on the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) and the Alzheimer's Disease Co-operative Study-Activities of Daily Living Inventory (ADCS-ADL) scales from baseline assessed at week 65 in the modified intention-to-treat population. This trial is registered with Clinicaltrials.gov (NCT01689246) and the European Union Clinical Trials Registry (2012-002866-11).</p><p><strong>Findings: </strong>Between Jan 29, 2013, and June 26, 2014, we recruited and randomly assigned 891 participants to treatment (357 to control, 268 to 75 mg LMTM twice a day, and 266 to 125 mg LMTM twice a day). The prespecified primary analyses did not show any treatment benefit at either of the doses tested for the coprimary outcomes (change in ADAS-Cog score compared with control [n=354, 6·32, 95% CI 5·31-7·34]: 75 mg LMTM twice a day [n=257] -0·02, -1·60 to 1·56, p=0·9834, 125 mg LMTM twice a day [n=250] -0·43, -2·06 to 1·20, p=0·9323; change in ADCS-ADL score compared with control [-8·22, 95% CI -9·63 to -6·82]: 75 mg LMTM twice a day -0·93, -3·12 to 1·26, p=0·8659; 125 mg LMTM twice a day -0·34, -2·61 to 1·93, p=0·9479). Gastrointestinal and urinary effects
背景:甲基硫鎓氯化物(Leuco-methylthioninium bis(hydromethanesulfonate;LMTM)是甲基硫鎓分子的一种稳定还原形式,在体外和转基因小鼠模型中均可作为 tau 蛋白聚集的选择性抑制剂。甲基硫鎓氯化物曾显示出作为单一疗法对阿尔茨海默病患者的潜在疗效。我们旨在确定 LMTM 是否能安全有效地改变轻度至中度阿尔茨海默病患者的疾病进展:我们在欧洲、北美、亚洲和俄罗斯 16 个国家的 115 个学术中心和私人研究诊所开展了一项为期 15 个月的随机对照双盲平行组试验,对象是年龄小于 90 岁的轻度至中度阿尔茨海默病患者。同时使用其他药物治疗阿尔茨海默氏症的患者被允许纳入试验范围,因为我们认为不允许他们参与试验是不可行的;但是,使用带有高铁血红蛋白血症警告的药物的患者被排除在外,因为高剂量的氧化型甲硫氨酸已被证明会诱发高铁血红蛋白血症。我们将参与者(3:3:4)随机分配到 75 毫克 LMTM(一天两次)、125 毫克 LMTM(一天两次)或对照组(4 毫克 LMTM(一天两次,以保持对尿液或粪便变色的盲法),均为口服片剂。我们使用交互式网络响应系统进行随机化,使用 600 个长度为 10 的区块,并根据患者的病情严重程度、全球地区、是否同时使用阿尔茨海默病药物以及 PET 的能力进行分层。在整个研究过程中,参与者、他们的研究伙伴(通常是照护者)和所有评估人员都对治疗任务进行了蒙蔽。主要研究结果是阿尔茨海默病评估量表-认知分量表(ADAS-Cog)和阿尔茨海默病合作研究-日常生活活动量表(ADCS-ADL)量表在基线基础上的进展情况,并在第65周对修改后的意向治疗人群进行评估。该试验已在Clinicaltrials.gov(NCT01689246)和欧盟临床试验注册中心(2012-002866-11)注册:2013年1月29日至2014年6月26日期间,我们招募并随机分配了891名参与者接受治疗(357人接受对照组治疗,268人接受75毫克LMTM治疗,每天两次,266人接受125毫克LMTM治疗,每天两次)。预设的主要分析结果显示,在测试的两个剂量下,均未显示出治疗对共同主要结果(与对照组相比,ADAS-Cog评分的变化[n=354,6-32,95% CI 5-31-7-34])有任何益处:75毫克LMTM,每天两次[n=257] -0-02,-1-60至1-56,p=0-9834,125毫克LMTM,每天两次[n=250] -0-43,-2-06至1-20,p=0-9323;与对照组相比,ADCS-ADL评分变化[-8-22,95% CI -9-63至-6-82]:75 毫克 LMTM,每天两次 -0-93,-3-12 至 1-26,p=0-8659;125 毫克 LMTM,每天两次 -0-34,-2-61 至 1-93,p=0-9479)。胃肠道和泌尿系统反应是两种高剂量 LMTM 最常见的不良反应,也是最常见的停药原因。非临床意义上的剂量依赖性血红蛋白浓度降低是最常见的实验室异常。与淀粉样蛋白相关的影像学异常在不到1%(8/885)的参与者中出现:本研究的主要分析结果为阴性,结果并不表明 LMTM 可作为轻度至中度阿尔茨海默病患者的附加治疗。最近完成的一项为期 18 个月的轻度阿尔茨海默病患者试验结果即将公布:TauRx Therapeutics。
{"title":"Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial.","authors":"Serge Gauthier, Howard H Feldman, Lon S Schneider, Gordon K Wilcock, Giovanni B Frisoni, Jiri H Hardlund, Hans J Moebius, Peter Bentham, Karin A Kook, Damon J Wischik, Bjoern O Schelter, Charles S Davis, Roger T Staff, Luc Bracoud, Kohkan Shamsi, John M D Storey, Charles R Harrington, Claude M Wischik","doi":"10.1016/S0140-6736(16)31275-2","DOIUrl":"10.1016/S0140-6736(16)31275-2","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Leuco-methylthioninium bis(hydromethanesulfonate; LMTM), a stable reduced form of the methylthioninium moiety, acts as a selective inhibitor of tau protein aggregation both in vitro and in transgenic mouse models. Methylthioninium chloride has previously shown potential efficacy as monotherapy in patients with Alzheimer's disease. We aimed to determine whether LMTM was safe and effective in modifying disease progression in patients with mild to moderate Alzheimer's disease.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We did a 15-month, randomised, controlled double-blind, parallel-group trial at 115 academic centres and private research clinics in 16 countries in Europe, North America, Asia, and Russia with patients younger than 90 years with mild to moderate Alzheimer's disease. Patients concomitantly using other medicines for Alzheimer's disease were permitted to be included because we considered it infeasible not to allow their inclusion; however, patients using medicines carrying warnings of methaemoglobinaemia were excluded because the oxidised form of methylthioninium in high doses has been shown to induce this condition. We randomly assigned participants (3:3:4) to 75 mg LMTM twice a day, 125 mg LMTM twice a day, or control (4 mg LMTM twice a day to maintain blinding with respect to urine or faecal discolouration) administered as oral tablets. We did the randomisation with an interactive web response system using 600 blocks of length ten, and stratified patients by severity of disease, global region, whether they were concomitantly using Alzheimer's disease-labelled medications, and site PET capability. Participants, their study partners (generally carers), and all assessors were masked to treatment assignment throughout the study. The coprimary outcomes were progression on the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) and the Alzheimer's Disease Co-operative Study-Activities of Daily Living Inventory (ADCS-ADL) scales from baseline assessed at week 65 in the modified intention-to-treat population. This trial is registered with Clinicaltrials.gov (NCT01689246) and the European Union Clinical Trials Registry (2012-002866-11).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Findings: &lt;/strong&gt;Between Jan 29, 2013, and June 26, 2014, we recruited and randomly assigned 891 participants to treatment (357 to control, 268 to 75 mg LMTM twice a day, and 266 to 125 mg LMTM twice a day). The prespecified primary analyses did not show any treatment benefit at either of the doses tested for the coprimary outcomes (change in ADAS-Cog score compared with control [n=354, 6·32, 95% CI 5·31-7·34]: 75 mg LMTM twice a day [n=257] -0·02, -1·60 to 1·56, p=0·9834, 125 mg LMTM twice a day [n=250] -0·43, -2·06 to 1·20, p=0·9323; change in ADCS-ADL score compared with control [-8·22, 95% CI -9·63 to -6·82]: 75 mg LMTM twice a day -0·93, -3·12 to 1·26, p=0·8659; 125 mg LMTM twice a day -0·34, -2·61 to 1·93, p=0·9479). Gastrointestinal and urinary effects","PeriodicalId":50026,"journal":{"name":"Journal of Systems Science & Complexity","volume":"29 1","pages":"2873-2884"},"PeriodicalIF":0.0,"publicationDate":"2016-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5164296/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74587871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"数学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Staged progression model for epidemic spread on homogeneous and heterogeneous networks. 同质和异质网络上流行病传播的阶段性进展模型。
IF 2.1 3区 数学 Q1 MATHEMATICS, INTERDISCIPLINARY APPLICATIONS Pub Date : 2011-01-01 Epub Date: 2011-06-11 DOI: 10.1007/s11424-011-8252-8
Haifeng Zhang, Michael Small, Xinchu Fu

In this paper, epidemic spread with the staged progression model on homogeneous and heterogeneous networks is studied. First, the epidemic threshold of the simple staged progression model is given. Then the staged progression model with birth and death is also considered. The case where infectivity is a nonlinear function of the nodes' degree is discussed, too. Finally, the analytical results are verified by numerical simulations.

本文研究了在同质和异质网络上使用分阶段进展模型的流行病传播。首先,给出了简单分阶段发展模型的流行阈值。然后还考虑了有出生和死亡的分阶段进展模型。此外,还讨论了传染性是节点度非线性函数的情况。最后,通过数值模拟验证了分析结果。
{"title":"Staged progression model for epidemic spread on homogeneous and heterogeneous networks.","authors":"Haifeng Zhang, Michael Small, Xinchu Fu","doi":"10.1007/s11424-011-8252-8","DOIUrl":"10.1007/s11424-011-8252-8","url":null,"abstract":"<p><p>In this paper, epidemic spread with the staged progression model on homogeneous and heterogeneous networks is studied. First, the epidemic threshold of the simple staged progression model is given. Then the staged progression model with birth and death is also considered. The case where infectivity is a nonlinear function of the nodes' degree is discussed, too. Finally, the analytical results are verified by numerical simulations.</p>","PeriodicalId":50026,"journal":{"name":"Journal of Systems Science & Complexity","volume":"24 4","pages":"619"},"PeriodicalIF":2.1,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089252/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37773159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"数学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NONLINEAR LANGEVIN MODEL WITH PRODUCT STOCHASTICITY FOR BIOLOGICAL NETWORKS: THE CASE OF THE SCHNAKENBERG MODEL. 生物网络具有产品随机性的非线性朗格万模型:以schnakenberg模型为例。
3区 数学 Q1 MATHEMATICS, INTERDISCIPLINARY APPLICATIONS Pub Date : 2010-10-01 Epub Date: 2010-11-09 DOI: 10.1007/s11424-010-0213-0
Youfang Cao, Jie Liang

Langevin equation is widely used to study the stochastic effects in molecular networks, as it often approximates well the underlying chemical master equation. However, frequently it is not clear when such an approximation is applicable and when it breaks down. This paper studies the simple Schnakenberg model consisting of three reversible reactions and two molecular species whose concentrations vary. To reduce the residual errors from the conventional formulation of the Langevin equation, the authors propose to explicitly model the effective coupling between macroscopic concentrations of different molecular species. The results show that this formulation is effective in correcting residual errors from the original uncoupled Langevin equation and can approximate the underlying chemical master equation very accurately.

朗之万方程被广泛地用于研究分子网络中的随机效应,因为它通常很好地近似于潜在的化学主方程。然而,通常不清楚这种近似何时适用,何时失效。本文研究了由三个可逆反应和两种不同浓度的分子组成的简单Schnakenberg模型。为了减少传统朗之万方程公式的残余误差,作者提出明确地模拟不同分子种宏观浓度之间的有效耦合。结果表明,该公式能有效地修正原始解耦朗之万方程的残余误差,并能很精确地逼近基础化学主方程。
{"title":"NONLINEAR LANGEVIN MODEL WITH PRODUCT STOCHASTICITY FOR BIOLOGICAL NETWORKS: THE CASE OF THE SCHNAKENBERG MODEL.","authors":"Youfang Cao,&nbsp;Jie Liang","doi":"10.1007/s11424-010-0213-0","DOIUrl":"https://doi.org/10.1007/s11424-010-0213-0","url":null,"abstract":"<p><p>Langevin equation is widely used to study the stochastic effects in molecular networks, as it often approximates well the underlying chemical master equation. However, frequently it is not clear when such an approximation is applicable and when it breaks down. This paper studies the simple Schnakenberg model consisting of three reversible reactions and two molecular species whose concentrations vary. To reduce the residual errors from the conventional formulation of the Langevin equation, the authors propose to explicitly model the effective coupling between macroscopic concentrations of different molecular species. The results show that this formulation is effective in correcting residual errors from the original uncoupled Langevin equation and can approximate the underlying chemical master equation very accurately.</p>","PeriodicalId":50026,"journal":{"name":"Journal of Systems Science & Complexity","volume":"23 5","pages":"896-905"},"PeriodicalIF":0.0,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11424-010-0213-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34899274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"数学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
An Agile MDA Approach for the Development of Service-Oriented Component-Based Applications 面向服务的基于组件的应用程序开发的敏捷MDA方法
IF 2.1 3区 数学 Q1 MATHEMATICS, INTERDISCIPLINARY APPLICATIONS Pub Date : 2008-11-08 DOI: 10.1109/CANS.2008.12
I. Lazar, B. Pârv, S. Motogna, I. Czibula, Codrut-Lucian Lazar
Agile Model Driven Architecture (MDA) software development processes apply agile principles in the context of executable models. In this paper we present an agile MDA approach for constructing, running, and testing executable UML service-oriented components. This work is part of a series referring to COMDEVALCO - a framework for Software Component Definition, Validation, and Composition.
敏捷模型驱动架构(MDA)软件开发过程在可执行模型的上下文中应用敏捷原则。在本文中,我们提出了一种敏捷的MDA方法,用于构造、运行和测试可执行的UML面向服务的组件。本工作是COMDEVALCO系列的一部分,COMDEVALCO是一个用于软件组件定义、验证和组合的框架。
{"title":"An Agile MDA Approach for the Development of Service-Oriented Component-Based Applications","authors":"I. Lazar, B. Pârv, S. Motogna, I. Czibula, Codrut-Lucian Lazar","doi":"10.1109/CANS.2008.12","DOIUrl":"https://doi.org/10.1109/CANS.2008.12","url":null,"abstract":"Agile Model Driven Architecture (MDA) software development processes apply agile principles in the context of executable models. In this paper we present an agile MDA approach for constructing, running, and testing executable UML service-oriented components. This work is part of a series referring to COMDEVALCO - a framework for Software Component Definition, Validation, and Composition.","PeriodicalId":50026,"journal":{"name":"Journal of Systems Science & Complexity","volume":"396 1","pages":"38-44"},"PeriodicalIF":2.1,"publicationDate":"2008-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88970054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"数学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
A Heuristic Chaotic Neural Network: Candidate Model for Perception 启发式混沌神经网络:感知的候选模型
IF 2.1 3区 数学 Q1 MATHEMATICS, INTERDISCIPLINARY APPLICATIONS Pub Date : 2008-11-08 DOI: 10.1109/CANS.2008.18
M. Ahmadlou, F. Mamashli, M. Golpayegani
In this paper a new Chaotic Neural Network (CNN) have been made. This network contains desired number of interacting units and each one has its own chaotic dynamic and strange attractor caused by creating convex hull among output units. Having a special interaction characteristic, the model is able to create enormous different chaotic behaviors. Lyapunov Exponent and phase space plane criteria have been used for demonstrating discrimination between behaviors. Making use of convex hull for trapping generated outputs of each unit in subsequent iteration, its folding characteristic and stretching property of logistic function, emerging of arbitrary number of various strange attractors have been accomplished. Therefore, based on desired criterion, this network is able to assign each strange attractor to each sensory input. In other words the network has the ability of being a candidate for modeling perception.
本文提出了一种新的混沌神经网络(CNN)。该网络包含期望数量的相互作用单元,每个单元都有自己的混沌动态和由输出单元之间产生凸包引起的奇异吸引子。该模型具有特殊的相互作用特性,能够产生大量不同的混沌行为。李雅普诺夫指数和相空间平面准则已被用来证明行为之间的区别。利用凸包在后续迭代中捕获每个单元的生成输出,实现了其折叠特性和逻辑函数的拉伸特性,以及任意数量的各种奇异吸引子的出现。因此,基于期望准则,该网络能够为每个感官输入分配每个奇怪的吸引子。换句话说,网络有能力成为建模感知的候选对象。
{"title":"A Heuristic Chaotic Neural Network: Candidate Model for Perception","authors":"M. Ahmadlou, F. Mamashli, M. Golpayegani","doi":"10.1109/CANS.2008.18","DOIUrl":"https://doi.org/10.1109/CANS.2008.18","url":null,"abstract":"In this paper a new Chaotic Neural Network (CNN) have been made. This network contains desired number of interacting units and each one has its own chaotic dynamic and strange attractor caused by creating convex hull among output units. Having a special interaction characteristic, the model is able to create enormous different chaotic behaviors. Lyapunov Exponent and phase space plane criteria have been used for demonstrating discrimination between behaviors. Making use of convex hull for trapping generated outputs of each unit in subsequent iteration, its folding characteristic and stretching property of logistic function, emerging of arbitrary number of various strange attractors have been accomplished. Therefore, based on desired criterion, this network is able to assign each strange attractor to each sensory input. In other words the network has the ability of being a candidate for modeling perception.","PeriodicalId":50026,"journal":{"name":"Journal of Systems Science & Complexity","volume":"875 1","pages":"85-93"},"PeriodicalIF":2.1,"publicationDate":"2008-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72662672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"数学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Certain Complexity Threshold during Growth of Functioning Networks 功能网络生长过程中一定的复杂性阈值
IF 2.1 3区 数学 Q1 MATHEMATICS, INTERDISCIPLINARY APPLICATIONS Pub Date : 2008-11-08 DOI: 10.1109/CANS.2008.16
A. Gecow
Certain threshold on network size axis was observed in statistical mechanisms of adaptive evolution. Now it is investigated. This threshold is connected with maturation of chaos and lies far above the critical point of percolation. It can be treated as complexity threshold defining the term 'complex network' for Kauffman chaotic networks. Distributions of damage size are obtained using simulation for a representative set of network parameters and network types (including scale-free, RBN and networks with more than two signal variants) for network sizes up to 4000 nodes. Based on them a criterion of the threshold is sought. We do not find any critical point in the investigated area, however a certain practical criterion is proposed. It is zero occurrence in-between two peaks of damage size frequency - left of real fadeout of damage which is ordered behaviour and right of equilibrium level after damage avalanche which is chaotic behaviour.
在适应进化的统计机制中,网络大小轴存在一定的阈值。现在正在进行调查。这一阈值与混沌的成熟有关,远高于渗流临界点。它可以作为复杂性阈值来定义考夫曼混沌网络中的“复杂网络”。通过对网络规模达4000个节点的网络参数和网络类型(包括无标度、RBN和具有两个以上信号变体的网络)的一组代表性网络参数和网络类型的模拟,获得了损伤大小的分布。在此基础上寻求阈值的标准。我们在研究区域没有发现任何临界点,但提出了一定的实用标准。损伤大小频率的两个峰值之间为零——损伤真实消退的左边为有序行为,损伤雪崩后平衡水平的右边为混沌行为。
{"title":"A Certain Complexity Threshold during Growth of Functioning Networks","authors":"A. Gecow","doi":"10.1109/CANS.2008.16","DOIUrl":"https://doi.org/10.1109/CANS.2008.16","url":null,"abstract":"Certain threshold on network size axis was observed in statistical mechanisms of adaptive evolution. Now it is investigated. This threshold is connected with maturation of chaos and lies far above the critical point of percolation. It can be treated as complexity threshold defining the term 'complex network' for Kauffman chaotic networks. Distributions of damage size are obtained using simulation for a representative set of network parameters and network types (including scale-free, RBN and networks with more than two signal variants) for network sizes up to 4000 nodes. Based on them a criterion of the threshold is sought. We do not find any critical point in the investigated area, however a certain practical criterion is proposed. It is zero occurrence in-between two peaks of damage size frequency - left of real fadeout of damage which is ordered behaviour and right of equilibrium level after damage avalanche which is chaotic behaviour.","PeriodicalId":50026,"journal":{"name":"Journal of Systems Science & Complexity","volume":"47 1","pages":"69-76"},"PeriodicalIF":2.1,"publicationDate":"2008-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91256861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"数学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Journal of Systems Science & Complexity
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1